BACKGROUND: The metabolic syndrome (MetS) is associated with incident myocardial infarction and stroke and is linked with subclinical inflammation; however, prospective data pertaining to MetS and future peripheral artery disease (PAD) are sparse, with few studies examining the role of inflammation. We therefore evaluated the relationship between MetS, inflammation, and incident PAD. METHODS AND RESULTS: We conducted a prospective cohort study among 27 111 women free of baseline cardiovascular disease who were participating in the Women's Health Study. Subjects were followed for incident symptomatic PAD (n=114; median cohort follow-up 13.3 years). We used Cox proportional hazards models to compare PAD risk among women with and without MetS. We also evaluated relationships between MetS and subclinical inflammation as measured by high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 and adjusted for these biomarkers in multivariable models. Women with MetS had a 62% increased risk of future PAD (hazard ratio 1.62, 95% confidence interval 1.10 to 2.38). After multivariable adjustment, MetS remained significantly associated with PAD (adjusted hazard ratio 1.48, 95% confidence interval 1.01 to 2.18), with a 21% risk increase per additional MetS-defining trait (adjusted hazard ratio 1.21, 95% confidence interval 1.06 to 1.39). In women with and without MetS, respectively, median levels of high-sensitivity C-reactive protein were 4.0 versus 1.5 mg/L (P<0.0001), and median levels of soluble intercellular adhesion molecule-1 were 374 versus 333 ng/mL (P<0.0001). When high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 were added to multivariable models, risk associated with MetS was substantially attenuated and no longer significant (hazard ratio 1.14, 95% confidence interval 0.75 to 1.73). CONCLUSIONS: MetS is associated with an increased risk of future symptomatic PAD in women. This risk appears to be mediated largely by the effects of inflammation and endothelial activation.
BACKGROUND: The metabolic syndrome (MetS) is associated with incident myocardial infarction and stroke and is linked with subclinical inflammation; however, prospective data pertaining to MetS and future peripheral artery disease (PAD) are sparse, with few studies examining the role of inflammation. We therefore evaluated the relationship between MetS, inflammation, and incident PAD. METHODS AND RESULTS: We conducted a prospective cohort study among 27 111 women free of baseline cardiovascular disease who were participating in the Women's Health Study. Subjects were followed for incident symptomatic PAD (n=114; median cohort follow-up 13.3 years). We used Cox proportional hazards models to compare PAD risk among women with and without MetS. We also evaluated relationships between MetS and subclinical inflammation as measured by high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 and adjusted for these biomarkers in multivariable models. Women with MetS had a 62% increased risk of future PAD (hazard ratio 1.62, 95% confidence interval 1.10 to 2.38). After multivariable adjustment, MetS remained significantly associated with PAD (adjusted hazard ratio 1.48, 95% confidence interval 1.01 to 2.18), with a 21% risk increase per additional MetS-defining trait (adjusted hazard ratio 1.21, 95% confidence interval 1.06 to 1.39). In women with and without MetS, respectively, median levels of high-sensitivity C-reactive protein were 4.0 versus 1.5 mg/L (P<0.0001), and median levels of soluble intercellular adhesion molecule-1 were 374 versus 333 ng/mL (P<0.0001). When high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 were added to multivariable models, risk associated with MetS was substantially attenuated and no longer significant (hazard ratio 1.14, 95% confidence interval 0.75 to 1.73). CONCLUSIONS: MetS is associated with an increased risk of future symptomatic PAD in women. This risk appears to be mediated largely by the effects of inflammation and endothelial activation.
Authors: David P Faxon; Valentin Fuster; Peter Libby; Joshua A Beckman; William R Hiatt; Robert W Thompson; James N Topper; Brian H Annex; John H Rundback; Rosalind P Fabunmi; Rose Marie Robertson; Joseph Loscalzo Journal: Circulation Date: 2004-06-01 Impact factor: 29.690
Authors: John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason Journal: N Engl J Med Date: 2004-04-01 Impact factor: 91.245
Authors: Naveed Sattar; Allan Gaw; Olga Scherbakova; Ian Ford; Denis St J O'Reilly; Steven M Haffner; Chris Isles; Peter W Macfarlane; Chris J Packard; Stuart M Cobbe; James Shepherd Journal: Circulation Date: 2003-07-14 Impact factor: 29.690
Authors: Jobien K Olijhoek; Yolanda van der Graaf; Jan-Dirk Banga; Ale Algra; Ton J Rabelink; Frank L J Visseren Journal: Eur Heart J Date: 2004-02 Impact factor: 29.983
Authors: Parveen K Garg; Mary L Biggs; Mercedes Carnethon; Joachim H Ix; Michael H Criqui; Kathryn A Britton; Luc Djoussé; Kim Sutton-Tyrrell; Anne B Newman; Mary Cushman; Kenneth J Mukamal Journal: Hypertension Date: 2013-11-04 Impact factor: 10.190
Authors: Yasuhiko Kubota; Aaron R Folsom; James S Pankow; Lynne E Wagenknecht; Weihong Tang Journal: Ann Epidemiol Date: 2017-12-16 Impact factor: 3.797
Authors: Himabindu Vidula; Kiang Liu; Michael H Criqui; Moyses Szklo; Matthew Allison; Christopher Sibley; Pamela Ouyang; Russell P Tracy; Cheeling Chan; Mary M McDermott Journal: Atherosclerosis Date: 2015-09-03 Impact factor: 5.162
Authors: S Marlene Grenon; Christopher D Owens; Hugh Alley; Karen Chong; Priscilla K Yen; William Harris; Millie Hughes-Fulford; Michael S Conte Journal: Vasc Med Date: 2013-09-19 Impact factor: 3.239
Authors: David Conen; Brendan M Everett; Tobias Kurth; Mark A Creager; Julie E Buring; Paul M Ridker; Aruna D Pradhan Journal: Ann Intern Med Date: 2011-06-07 Impact factor: 25.391
Authors: S Marlene Grenon; Michael S Conte; Emily Nosova; Hugh Alley; Karen Chong; William S Harris; Eric Vittinghoff; Christopher D Owens Journal: J Vasc Surg Date: 2013-07-02 Impact factor: 4.268
Authors: Hassan Albadawi; Rahmi Oklu; Nicholas R Cormier; Ryan M O'Keefe; James T Heaton; James B Kobler; William G Austen; Michael T Watkins Journal: J Surg Res Date: 2014-01-17 Impact factor: 2.192